chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She is constantly tired and extremely beyond tired and her body still aches and this all started from the vaccines; She is constantly tired and extremely beyond tired and her body still aches and this all started from the vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Apr2021 (Lot number: ER8731) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Bipolar" (unspecified if ongoing); "Acute anxiety disorder" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM taken for anxiety; OLANZAPINE; LITHIUM. Vaccination history included: Bnt162b2 (Dose no: 1, Time: 15:00, Anatomical location: Left arm, Lot number: ERG733), administration date: 24Mar2021, when the patient was 58 years old, for COVID-19 immunization, reaction(s): "She is having chronic fatigue", "loss of appetite", "body aches", "no energy", "sporadic headaches", "wants to sleep all the time", "Unsteadiness on her feet". The following information was reported: FATIGUE (non-serious), PAIN (non-serious) all with onset Apr2021, outcome "unknown" and all described as "She is constantly tired and extremely beyond tired and her body still aches and this all started from the vaccines".  Additional information: Olanzapine, Alprazolam, Lithium Taking for 24 years. It was reported she gets the second dose 14Apr2021 and it all started all over. Now she is in Jun2021 and she is constantly tired and extremely beyond tired and her body still aches and this all started from the vaccines. She was wondering if the vaccine is triggering and increasing her lithium levels, something is going on and all started since the vaccine. At this point she is wanting to report it and if another person is on these medication so they can start connecting dots. She wanted to know if vaccine increased lithium levels. She is picking lithium since it interacts with everything. She wanted to know if anything or anybody else calling up or is this interaction to Lithium. Could the vaccine be increasing her lithium levels. She has been on Lithium since 1996, for 24 years she has been on 900mg of the product. No additional vaccines on same date. Events not resulted in Emergency Room or Physician Office visit. No Prior Vaccinations within 4 weeks. patient was vaccinated when she was a baby.   No follow-up attempts are possible. No further information is expected.
Patient seemed nervous about receiving his first Covid vaccine.  Shortly after the administration he said he felt like he was going to faint. I put some cold rags on the back of his neck and forehead.  Ten minutes later he started to feel better.  He was able to leave the pharmacy with his son.
Immediately after receiving vaccine, I had an increased heart rate. Seconds lately felt very dizzy/weak like I was going to pass out. Had to lay down on the ground for 10 minutes. A few minutes after receiving the vaccine my arm I got the shot in started tingling and felt some numbness in my arm and finger tips. Same side of my ear also started tingling and felt numb. Tingling and some numbness  lasted on and off for the rest of the evening.
Low-grade fever starting at hour 12 and lasting over 24 hours. Soreness at the injection site lasting over 48 hours. Exacerbation of chronic myofascial pain syndrome starting at hour seven and lasting over 24 hours.
Mild urticaria  Negative respiratory symptoms.  No edema. Treatment - Benadryl by mouth.
Lump in arm next day followed by very red arm 4?x 2? for over three weeks.
sore throat; Congestion; Cough; Headache; body aches; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: ER8733) via an unspecified route of administration in the arm left on 29Mar2021(at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included back ache, neuropathy, depression, cancer. The patient had allergies to FLAGYL and IV contrast. The patient received unknown concomitant medications. The patient had received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number; EJ1685) vaccine for COVID-19 immunisation on 08Mar2021, in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 (Tuesday) about 02:00, the patient woke up with sore throat, congestion, headache, cough. At 06:30, woke up with the same symptoms, in addition, had body aches and fever of 101. Slept off and on. At 06:30, still had all symptoms but fever was 103. The patient called primary physician, but he said was probably side effects, but if condition worsened or had shortness of breath then visit the emergency room, also recommended to get Covid test the next day. Fever broke and by 23:15 was just below 100. Woke up on Wednesday, all symptoms were gone but the cough, some congestion and headache. The patient took Tylenol, and headache went away. The events had not resulted in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore throat, headache, body aches and fever was recovered with sequelae. The clinical outcome for congestion and cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Received vaccinations 01/20/2005. Symptoms started 05:30 AM 01/21/2005 with abdominal pain , dizziness and sweats without fever , nausea and vomiting : has diarrhea. Sole of feet itchy : the skin red from head to toes. Most symptoms gone in approx 3 hours, though abdominal pain persisted for several days. Also , bloody stools for 3 - 4 days.
Child has fever to 103.5 headache "both arms hurt" redness at injection site and frequent cleaning of throat.  Encouraged to increased po fluids, TYLENOL/MOTRIN for fever/comfort & warm compresses to arms.
shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a health care provider (HCP) for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
She almost instantly completely lost hearing in her right ear / loss of hearing; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on 28Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported she had the first shot of the vaccine on 28Jan2021, then on 30Jan2021 she reported that she almost instantly completely lost hearing in her right ear. She said it hasn't changed since. She already had a CT scan and MRI scan with her doctor, and she wanted to eliminate the vaccine shot as the cause of her loss of hearing. Outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Atypical febrile seizure temp to 104.3 (x 2)
2nd shot, BP high again for 48 hours 164/107; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 03Mar2021 15:00 (Lot number: EN6202) at the age of 66 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "A-Flutter", start date: 11Mar2021 (unspecified if ongoing), notes: Pertinent details: 04Aug2021 had ablation to correct atrial flutter; "Inflamation of shoulder" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN taken for inflammation (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Batch/Lot Number: EL9265, Anatomical Site of Injection: Left arm, Route of administration: Intramuscular), administration date: 10Feb2021, when the patient was 66 years old, for Covid-19 immunization, reaction(s): "felt extremely unwell", "no appetite", "felt sick", "no energy", "BP 194/110". The following information was reported: HYPERTENSION (non-serious), outcome "recovered", described as "2nd shot, BP high again for 48 hours 164/107". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Family Medical History Relevant to AE(s) reported as no previous high BP nor A-Flutter . Follow-up attempts are completed. No further information is expected.
approximately one hour post Pfizer injection, the pt was beginning a routine exam and became hypotensive and bradycardic. She was given 500cc of normal saline via IV at 12:08. Her vitals were raised to normal and she was dismissed after fluid administration.
Throat swelling, tongue swelling, and swelling under the left axilla. I went to the emergency dept., then transported via EMS to hospitals.
There is no adverse event. This report is done because of the request of CDC staff memeber. What happened is patient was supposed to get Hep B dialysis dose which is 40 mcg. Our clinic has 20 mcg/ml in vial and pt was given 1 shot which is half of the dose that he was supposed to receive.
5:30pm 2/22/21 started feeling ache ate dinner: 7:30pm started vomiting with fever of 100: 9pm sever chills with sweats:  9:30pm vomited layed down: 1am woke sweating shivering fever still 100 took a shover started extreme body aches with chest pain: drove myself to Stony Brook ED: labs ran covid swabbed still with all symptoms: chest xray preformed: released at 6am was told to monitor symptoms and if I can not keep anything down like water and or still with chest pain after 24hrs return to ED
Abdominal pain (left rib); Body ache; Fever; Problem breathing, shortness of breath and it was hard to breath; Throat was closing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Problem breathing, shortness of breath and it was hard to breath), THROAT TIGHTNESS (Throat was closing), ABDOMINAL PAIN (Abdominal pain (left rib)), PAIN (Body ache) and PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DYSPNOEA (Problem breathing, shortness of breath and it was hard to breath). 13-Jan-2021, the patient experienced THROAT TIGHTNESS (Throat was closing). On 15-Jan-2021, the patient experienced ABDOMINAL PAIN (Abdominal pain (left rib)), PAIN (Body ache) and PYREXIA (Fever). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Problem breathing, shortness of breath and it was hard to breath), THROAT TIGHTNESS (Throat was closing), ABDOMINAL PAIN (Abdominal pain (left rib)), PAIN (Body ache) and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also included unspecified antihistamine. Concomitant medications included natural supplements for seasonal allergies.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-APR-2021 included: No new information
Information has been received from a registered nurse concerning a 20 week old infant who was vaccinated on 13-Nov-2006 with an oral dose of Rotateq (human bovine). No problems were reported. It was not reported if medical attention was sought.  There was no product quality complaint involved. Additional information is not expected.
Red itchy bumps on skin, predominantly on arms, started to develop 12/15/03 and progressed over the next 2 days. Pt evaluated by Dermatology 12/17/03. Dx urticarial exanthema. Rx'd Benadryl.
Pt reports 5 minutes after getting the vaccination she became nauseous, her chest felt tight, she got a headache, became light headed and her arms and legs began to shake. She stated she had slight SOB.
Patient became pale and syncopal after vaccine administered. After being stabalized on floor, she underwent a seizure and 1 minute loss of consciousness. 911 called and pt vital signs monitored, vital signs stable and no sign of distress.
Per chart note from 6/1/21, pt had hives day after COVID vaccine w/extensive erythema, lip swelling. She was admitted to hospital for 4 hrs & treated w/Benadryl & steroids. Pt will not receive 2nd dose
temp and it was 101.6; very tired; feel achy (shoulders, upper back and chest); feel achy (shoulders, upper back and chest); feel achy (shoulders, upper back and chest); feel achy (shoulders, upper back and chest); slight pain at injection site; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 25Feb2021 at 16:00 (Batch/Lot Number: EN6202) (at the age of 55 years old) as dose number unknown, single for COVID-19 immunisation. Medical history included was diagnosed with COVID-19 prior to vaccination. The patient had not been tested with COVID-19 since the vaccination. The patient had no known allergies. Concomitant medications included VITAMIN D, 5000 IU; "statin 20 mg; both taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines in 4 weeks. The patient experienced slight pain at injection site on 26Feb2021 at 07:00; feel achy (shoulders, upper back and chest) on 26Feb2021 at 09:00; very tired on 26Feb2021 at 19:00; temp and it was 101.6 on 26Feb2021 at 20:00. The course of the events was as follows: Shot 25Feb2021 at 16:00. No issue that day. 26Feb2021 at 7:00 am slight pain at injection site. 9:00 am began to feel achy (shoulders, upper back and chest. Took temp, was 98.7. Took 800 mg Ibuprofen at 11:00, laid down from 11:30-noon. Got up felt good by 15:30 pm no aches only injection site pain but less than in the am. Took a nap at 15:30 and stayed in bed till 19:00, very tired. Got up had dinner and right after felt achy again. Laid on couch with two blankets. 20:00 took temp and it was 101.6. Took 800 mg Ibuprofen. The outcome of event slight pain at injection site was recovering; while outcome for events feel achy (shoulders, upper back and chest), very tired and temp and it was 101.6 was unknown. No follow-up attempts are possible. No further information is expected.
Had the first dose of the Pfizer Vaccine; Came down with Covid; This is a spontaneous report from a non-contactable consumer (patient's wife) from a Pfizer-sponsored program. This is the second case out of two cases in which the reporter is reporting for her husband. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: unknown), via an unspecified route of administration on 02Aug2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Reportedly, the reporter and her husband had the first dose of the Pfizer Vaccine on 02Aug2021, and on 10Aug2021, they both came down with Covid, 8 days after. So, they were out of quarantine on the 22Aug2021 (22nd of this month) and now they want to go get their second dose, but the doctor told them that they have to wait 90 days. The patient underwent lab tests and procedures which included Covid Test: came down with covid on 10Aug2021. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101106375 Same reporter/drug/event, different patient.
WITH IN 24 HOURS LARYNGITIS WITH IN 36 HOURS UPPER RESPIRATORY INFECTION INCLUDING INABILITY TO EQUALIZE EARS, HEARING AFFECTED ADDED TO SYMPTOM WITH IN 48 HOURS FEVER, DEEP COUGHING, WHEEZING DIFFICULTY BREATHING  ADDED TO SYMPTOMS. WILL REQUIRE DOCTOR VISIT TO ELIMIANTE SECONDARY BACTERIAL INFECTION.
This spontaneous report was received from a certified medical assistant regarding unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patient was vaccinated with improperly stored PNEUMOVAX 23 lot # L019836/expiration date-24-MAR-2017. No adverse event was reported. The outcome of the event was unknown. Temperature excursion was 35 F and 52.5 F for unspecified time. There was no previous temperature excursion and call was not because of the data logger. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information is not expected as reporter does not wants to get contacted.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age. On 07-FEB-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # H010661, expiration date 02-FEB-2014) (dose unknown) via intramuscular route. No known adverse effects. Additional information is not expected.
Information has been received from a healthcare worker concerning a 5 year old female with no medical history or drugs allergies, who on 06-DEC-2004 was vaccinated with a 0.5 mL first dose of VARIVAX (Merck), subcutaneously. On 09-APR-2009 the patient received a second dose of VARIVAX (lot # 661659/1136X).  Secondary suspect vaccination given on the same date included a dose of Hep A into the left deltoid.  On 09-APR-2009 the patient developed a large, itchy hive at the injection site of the left upper arm 5-6 hours after receiving her second dose of VARIVAX (Merck).  The injection site reaction resolved in 1 day without requiring treatment.  No laboratories studies performed.  The patient sought unspecified medical attention.  Additional information is not expected.
Moderna COVID-19 Vaccine EUA Experiencing hyper-alertness and difficulty focusing. Having anxiety/emotional side effects. Feels like I've drank several cups of coffee. Diet is regular/healthy, have had no major changes in last 48 hours.
Terrible Headaches  since day one of the Vaccine , also accompanied whit a little temperature.
10/26/2022 reported to employee health that symptoms included chills, fatigue, severe headache, face inflammation and nerve pain
Patient given the HPV vaccine unaware at the time the patient was pregnant.  No adverse reaction noted.
Bladder cancer/ Carcinoma in situ; This spontaneous case was reported by a patient and describes the occurrence of BLADDER CANCER (Bladder cancer/ Carcinoma in situ) in a 67-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLADDER CANCER (Bladder cancer/ Carcinoma in situ) (seriousness criterion medically significant). At the time of the report, BLADDER CANCER (Bladder cancer/ Carcinoma in situ) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2023, Biopsy bladder: diagnosed with CIS. On an unknown date, Blood pressure measurement: High.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. It was reported that bladder cancer was diagnosed with CIS on 04-May-2023, based on the results of a biopsy of bladder. However, since there was a worldwide shortage of BCG, patient will most likely not receive a full BCG dosage during bladder instillations. Plus, patient had the Moderna Covid-19 vaccine, and recently heard that Moderna had good initial results with their pancreatic mRNA vaccine. Patient had high blood pressure other than CIS and was generally good health.The patient states it wasn't  intentional that patient was diagnosed after receiving the Moderna COVID19 Vaccine. The patient explains that cancer was diffused between all the cells. It's not a tumor. It's called carcinoma in situ.  No treatment medication was provided.  Company comment- This is a spontaneous case concerning a 67-year-old male patient with no medical history reported who experienced the unexpected and serious (medically significant) event bladder cancer. A dose of mRNA-1273.222 (Original/Omicron BA.4/5) vaccine was administered on an unknown day, hence latency cannot be assessed. It was reported that bladder cancer (carcinoma in situ) was diagnosed, based on the results of a biopsy of bladder. No further details were provided for medical review.  The benefit-risk relationship of the mRNA-1273.222 (Original/Omicron BA.4/5) vaccine is not affected by this report.   Reporter did not allow further contact
Information has been received from a physician through the pregnancy registry concerning a 15 year old female who on approximately 20-JAN-2007 was vaccinated intramuscularly with 0.5 ml of Gardasil (yeast). On that same day, concomitant therapy included Menactra and Adacel. It was reported that shortly after getting home, the patient developed nausea and vomiting. The patient was seen by the physician and found also to be pregnant. On an unspecified date, the patient underwent a pregnancy test. At the time of this report, the outcome of the events were unknown. Additional information has been requested. 07/08/2008 No further information is expected.
ASTMA ATTACK.  COULDN'T BREATHE NORMALLY.  SORE THROAT.  SORE ARM AT INJECTION SITE.